| 12428479 |
CLDN18.2-targeting antibody, bispecific antibody and use thereof |
Ming-Jin Jheng, Yongqiang Wang, Yun ZHANG, Chuchu ZHAO, Yunxing Yang +3 more |
2025-09-30 |
| 12378299 |
CD80 variant proteins and uses thereof |
Yuntao Song, Jianhui Zhou, Ping Hui Szu, Chen Dong |
2025-08-05 |
| 12011475 |
Polypeptide, polypeptide fragment, derivative thereof, and applications thereof |
De WEI, Xiaomei Li, Wen YU, Xiaohong Chen, Ling XIAO +2 more |
2024-06-18 |
| 11891446 |
Highly potent antibodies binding to death receptor 5 |
Kyung Jin Kim, Hangil Park, Lihong Wang, April Zhang, Maximiliano Vasquez |
2024-02-06 |
| 11485782 |
Anti-claudin 18.2 antibodies |
Yuntao Song, Chen Dong, Zhiwei Li, John Lippincott, Ping Hui Szu |
2022-11-01 |
| 10941204 |
Highly potent antibodies binding to death receptor 4 |
Kyung Jin Kim, Hangil Park, Lihong Wang, April Zhang, Maximiliano Vasquez |
2021-03-09 |
| 9486434 |
Method for delivery and use of isothiocyanates for prophylaxis and/or therapy of bladder cancer |
Yuesheng ZHANG, Arup Bhattacharya, Li Tang, Yun Li, Joseph D. Paonessa +1 more |
2016-11-08 |